<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140415017288N7</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-06</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Effect of Exercise and Spirulina on Elderly Men</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Aerobic Training with Spirulina Supplementation on Mitochondrial-Derived Peptides, Inflammatory factors and Heart damage in Overweight Elderly Men</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54708</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Health service research, Randomization description: In this research, subjects are selected Simple randomization by random allocation rule. After determining the sample size, they will be equally divided into five groups (1- Control, 2-  Overweight, 3- Overweight + Exercise, 4- Overweight + Spirulina and 5- Overweight + Exercise + Spirulina). Using the lottery method, the names of the subjects are written on separate papers and placed in a container, then the names of the subjects are randomly taken out and placed in the intervention groups or placebo, respectively, Blinding description: The Overweight + Spirulina and Overweight + Exercise + Spirulina patients receive Spirulina (1000 mg/day), two capsules orally of 500 mg twice daily before breakfast and dinner for 8 weeks. Control, Overweight and Overweight + Exercise groups receive placebo in the same pharmacological presentation. Starch is used as placebo.</study_design>
      <phase>3</phase>
      <hc_freetext>overweight elderly men.</hc_freetext>
      <i_freetext>Intervention 1: Control group: in this group we have not any intervention during 8 weeks, and will consider this group as placebo. Intervention 2: Intervention group: Training group (in this group for eight week, three session/weeks, the training start with 10 min warming and then 40 min training with 65% Peak heart rate, which in the final weeks reaches 80% of the heart rate). Intervention 3: Intervention group: Spirulina supplementation group (in this group eat 1000 mg of spirulina supplementation for eight weeks Twice a day before breakfast and dinner). Intervention 4: Intervention group: Training+spirulina supplementation group (In this group the Simultaneous intervention, training and spirulina supplementation, will treat with the same protocol that describe at the previous part).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The report is submitted to the research department of the university. Also published as a paper.

When:
Since 2021

To whom:
All researchers

Conditions:
Citing references

Where to obtain:
Scientific bases and Ayatollah Amoli Branch, Islamic Azad University, amol, Iran

How to obtain:
Maximum one week

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ahmad Abdi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ayatollah Amoli Branch, Islamic Azad University</address>
        <city>Amol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>678</zip>
        <telephone>+98 11 4321 7124</telephone>
        <email>a.abdi@iauamol.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Alireza Barari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ayatollah Amoli Branch, Islamic Azad University</address>
        <city>Amol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>678</zip>
        <telephone>+98 11 4321 7126</telephone>
        <email>alireza54.barari@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range in the range of 50-65 years
BMI more than 25 kg per square meter
Inactive lifestyle (exercise less than 1 hour per week)
Do not use the drug in 6 months
No person or family has Covid disease 19
Satisfaction to participate in the study</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>65 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Take supplements and practice before starting the protocol
Detection of other underlying diseases during the implementation of the protocol, such as cardiopulmonary problems and musculoskeletal disorders during exercise that prevent the performance of the activity
Covid 19 disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Overweight</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Placebo</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: in this group we have not any intervention during 8 weeks, and will consider this group as placebo.</i_keyword>
      <i_keyword>Intervention group: Training group (in this group for eight week, three session/weeks, the training start with 10 min warming and then 40 min training with 65% Peak heart rate, which in the final weeks reaches 80% of the heart rate).</i_keyword>
      <i_keyword>Intervention group: Spirulina supplementation group (in this group eat 1000 mg of spirulina supplementation for eight weeks Twice a day before breakfast and dinner).</i_keyword>
      <i_keyword>Intervention group: Training+spirulina supplementation group (In this group the Simultaneous intervention, training and spirulina supplementation, will treat with the same protocol that describe at the previous part).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on Humanin. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on mitochondrial ORF of the 12S rRNA type-c (MOTS-c). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on Transforming growth factor beta 1 (TGF-β1). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on Tumor necrosis factor alpha (TNF-α). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on Growth Differentiation Factor 15 (GDF15). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on N-terminal pro-brain natriuretic peptide (NTproBNP). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on E-selectin. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on Ghrelin. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on Nesfatin-1. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on Obstatin. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on YY peptide. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on sICAM-1. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on sVCAM-1. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on E-selectin. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
      <prim_outcome>Effect of aerobic training and spirulina supplementation on endothelin-1. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-03-01</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University - Marvdasht Branch</contact_name>
        <contact_address>3 km of Marvdasht-Persepolis Boulevard, Islamic Azad University, Marvdasht Branch Marvdasht Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-12-26</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University - Marvdasht Branch</contact_name>
        <contact_address>3 km of Marvdasht-Persepolis Boulevard, Islamic Azad University, Marvdasht Branch Marvdasht Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
